A/Prof John Ding
Honorary Clinical Associate Professor
Department of Medicine
170 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
980 RANDOMISED CONTROLLED TRIAL OF CONTINUED INTRAVENOUS VERSUS SWITCHING TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: THE SUBCUTANEOUS INFLIXIMAB SWITCH STUDY (SISS).
DOI: 10.1016/s0016-5107(26)02347-32024
Research grants (ARC, NHMRC, MRFF)
Prospective Randomised Controlled Trial of Adult Patients With Perianal Fistulising Crohn\2019s Disease and Optimised Therapeutic Infliximab Levels (PROACTIVE)
2020
Journal article
Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
DOI: 10.1016/S2468-1253(20)30121-72019
Journal article
Efficacy of Endoscopic Dilation of Gastroduodenal Crohn's Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data
DOI: 10.1016/j.cgh.2018.11.0482018
Journal article
Validation of the 'United Registries for Clinical Assessment and Research' [UR-CARE], a European online registry for clinical care and research in inflammatory bowel disease
DOI: 10.1093/ecco-jcc/jjy0152018
Journal article
Editorial: anti-TNF therapy and myopenia in Crohn's disease—another step towards personalised medicine. Authors’ reply
DOI: 10.1111/apt.144092017
Journal article
The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm
DOI: 10.1111/apt.14293
RECENT SCHOLARLY WORKS
2026
Journal article
980 RANDOMISED CONTROLLED TRIAL OF CONTINUED INTRAVENOUS VERSUS SWITCHING TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: THE SUBCUTANEOUS INFLIXIMAB SWITCH STUDY (SISS).
DOI: 10.1016/s0016-5085(26)02416-92026
Journal article
Letter: Steroid Tapering—Is Shorter Duration Better?
DOI: 10.1111/apt.706222026
Journal article
Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease
DOI: 10.1111/apt.703402026
Journal article
Defining Radiological Healing in Perianal Fistulizing Crohn’s Disease: A TOpClass Global Expert Delphi Consensus
DOI: 10.1016/j.cgh.2025.02.0092026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.0202025
Journal article
Infliximab-Induced Immune Thrombocytopenic Purpura in an Ulcerative Colitis Patient
DOI: 10.1159/0005459222025
Journal article
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium
DOI: 10.1002/jgh3.703222025
Journal article
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn’s disease
DOI: 10.1186/s13244-025-01930-w